Hsiao, Chi-Huang

Head of Division of Oncology and Hematology

Specialty

Medical Oncology and Hematology, especially lung cancer, breast cancer, and colo-rectal cancer.

Expertise in cancer diagnosis and treatment planning, chemotherapy and targeted therapy.


Lin, Shih-Chiang

Current Position

1. Attending physician, devision of oncology and hematology, department of internal medicine, Far Eastern Memorial Hospital

2. Ward chief, devision of oncology and hematology, department of internal medicine, Far Eastern Memorial Hospital

3. Attending physician (part time), devision of hematology, department of internal medicine, National Taiwan University Hospital

4. Master student, graduate institute of clinical medicine, college of medicine, National Taiwan University

Core Ability

1. Treatment and study of leukemia, lymphoma and multiple myeloma

2. Treatment of anemia, thrombocytopenia, coagulopathy and other hematology disease 3. Bone marrow and peripheral blood stem cell transplantation

Publication

1. Pei-Wei Shueng, Shih-Chiang Lin, Ngot-Swan Chong, Hsing-Yi Lee, Hui-Ju Tien, Le-Jung Wu, et al.Total Marrow Irradiation with Helical Tomotherapy for Bone Marrow Transplantation of Multiple Myeloma: First Experience in Asia. Technology in Cancer Research and Treatment, 2009; 8: 29-38. (SCI) IF:1.951

2. Pei-Wei Shueng, Shih-Chiang Lin, Hou-Tai Chang, Ngot-Swan Chong, Yu-Jen Chen, Li-Ying Wang, Yen-Ping Hsieh, Chen-Hsi Hsieh. Toxicity risk of non-target organs at risk receiving low-dose radiation: case report. Radiation Oncology 2009, 4:71 (SCI) IF:2.043

Hsieh, Pei-Ying

Lin, Yu-Chin

Current Position

1. Attending physician, division of oncology and hematology, department of internal medicine, Far Eastern Memorial Hospital

2. Attending physician (part time), department of oncology, National Taiwan Univeristy Hospital

3. PhD student, graduate school of pharmacology, college of medicine, National Taiwan University

Core Ability

1. Molecular targeted therapy and biomarker study of head and neck cancer

2. Mechanism of anti-cancer drugs for colorectal, lung, and breast cancer

3. Cancer clinical trial

Publication

1. Disseminated peritoneal leiomyomatosis responds to systemic chemotherapy. Lin YC, Wei LH, Shun CT, Cheng AL, Hsu CH. Oncology. 2009;76(1):55-8. Epub 2008 Nov 27.

2. Clinicopathologic features and treatment outcome of non-Hodgkin lymphoma of the breast--a review of 42 primary and secondary cases in Taiwanese patients. Lin YC, Tsai CH, Wu JS, Huang CS, Kuo SH, Lin CW, Cheng AL. Leuk Lymphoma. 2009 Jun;50(6):918-24.